These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 954813)
1. A new probe for heterogeneity in muscarinic receptors: 2-methyl-spiro-(1, 3-dioxolane-4, 3')-quinuclidine. Fisher A; Weinstock M; Gitter S; Cohen S Eur J Pharmacol; 1976 Jun; 37(2):329-38. PubMed ID: 954813 [TBL] [Abstract][Full Text] [Related]
2. A study of muscarinic receptor heterogeneity with weak antagonists. Fisher A; Grunfeld Y; Weinstock M; Gitter S; Cohen S Eur J Pharmacol; 1976 Jul; 38(1):131-9. PubMed ID: 954822 [TBL] [Abstract][Full Text] [Related]
3. Does rigidity in structure of muscarinic agonists and antagonists reflect drug specificity? Fisher A; Abraham S; Lachman C; Lass Y; Akselrod S; Akerman E; Cohen S Monogr Neural Sci; 1980; 7():41-54. PubMed ID: 7231438 [TBL] [Abstract][Full Text] [Related]
4. (+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease. Fisher A; Brandeis R; Karton I; Pittel Z; Gurwitz D; Haring R; Sapir M; Levy A; Heldman E J Pharmacol Exp Ther; 1991 Apr; 257(1):392-403. PubMed ID: 2019998 [TBL] [Abstract][Full Text] [Related]
5. Peripheral and central muscarinic receptor affinity of psychotropic drugs. Fjalland B; Christensen AV; Hyttel J Naunyn Schmiedebergs Arch Pharmacol; 1977 Dec; 301(1):5-9. PubMed ID: 600320 [TBL] [Abstract][Full Text] [Related]
6. The actions of some esters of 4-hydroxyquinuclidine on guinea-pig ileum, atria and rat fundus strip. Barlow RB; Kitchen R Br J Pharmacol; 1982 Nov; 77(3):549-57. PubMed ID: 7139202 [TBL] [Abstract][Full Text] [Related]
7. 5-Methyl-2-pyrrolidone analogues of oxotremorine as selective muscarinic agonists. Ringdahl B J Med Chem; 1988 Mar; 31(3):683-8. PubMed ID: 3346881 [TBL] [Abstract][Full Text] [Related]
9. SB 202026: a novel muscarinic partial agonist with functional selectivity for M1 receptors. Loudon JM; Bromidge SM; Brown F; Clark MS; Hatcher JP; Hawkins J; Riley GJ; Noy G; Orlek BS J Pharmacol Exp Ther; 1997 Dec; 283(3):1059-68. PubMed ID: 9399977 [TBL] [Abstract][Full Text] [Related]
10. Central cholinergic agents. III. Synthesis of 2-alkoxy-2,8- diazaspiro[4.5]decane-1,3-diones as muscarinic agonists. Ishihara Y; Yukimasa H; Miyamoto M; Goto G Chem Pharm Bull (Tokyo); 1992 May; 40(5):1177-85. PubMed ID: 1394631 [TBL] [Abstract][Full Text] [Related]
11. Regional differences in receptor reserve for analogs of oxotremorine in vivo: implications for development of selective muscarinic agonists. Ringdahl B; Roch M; Jenden DJ J Pharmacol Exp Ther; 1987 Aug; 242(2):464-71. PubMed ID: 3612545 [TBL] [Abstract][Full Text] [Related]
12. Muscarinic activity and receptor binding of the enantiomers of aceclidine and its methiodide. Ringdahl B; Ehler FJ; Jenden DJ Mol Pharmacol; 1982 May; 21(3):594-9. PubMed ID: 6125875 [TBL] [Abstract][Full Text] [Related]
13. Stereochemical requirements for central and peripheral muscarinic and antimuscarinic activity of some acetylenic compounds related to oxotremorine. Dahlbom R; Jenden DJ; Resul B; Ringdahl B Br J Pharmacol; 1982 Jun; 76(2):299-304. PubMed ID: 7093587 [TBL] [Abstract][Full Text] [Related]
14. Muscarinic activity of some secondary and tertiary amines and quaternary ammonium salts structurally related to oxotremorine. Resul B; Ringdahl B; Dahlbom R; Jenden DJ Eur J Pharmacol; 1983 Mar; 87(4):387-96. PubMed ID: 6852095 [TBL] [Abstract][Full Text] [Related]
15. In vivo antimuscarinic actions of the third generation antihistaminergic agent, desloratadine. Howell G; West L; Jenkins C; Lineberry B; Yokum D; Rockhold R BMC Pharmacol; 2005 Aug; 5():13. PubMed ID: 16109168 [TBL] [Abstract][Full Text] [Related]
16. Serotonergic potentiation of muscarinic agonist evoked tremor and salivation in rat and mouse. Ogren SO; Carlsson S; Bartfai T Psychopharmacology (Berl); 1985; 86(3):258-64. PubMed ID: 3929296 [TBL] [Abstract][Full Text] [Related]
17. Xanomeline compared to other muscarinic agents on stimulation of phosphoinositide hydrolysis in vivo and other cholinomimetic effects. Bymaster FP; Carter PA; Peters SC; Zhang W; Ward JS; Mitch CH; Calligaro DO; Whitesitt CA; DeLapp N; Shannon HE; Rimvall K; Jeppesen L; Sheardown MJ; Fink-Jensen A; Sauerberg P Brain Res; 1998 Jun; 795(1-2):179-90. PubMed ID: 9622623 [TBL] [Abstract][Full Text] [Related]
18. L-689,660, a novel cholinomimetic with functional selectivity for M1 and M3 muscarinic receptors. Hargreaves RJ; McKnight AT; Scholey K; Newberry NR; Street LJ; Hutson PH; Semark JE; Harley EA; Patel S; Freedman SB Br J Pharmacol; 1992 Oct; 107(2):494-501. PubMed ID: 1422595 [TBL] [Abstract][Full Text] [Related]
19. Tertiary 3- and 4-haloalkylamine analogues of oxotremorine as prodrugs of potent muscarinic agonists. Ringdahl B; Roch M; Jenden DJ J Med Chem; 1988 Jan; 31(1):160-4. PubMed ID: 3336014 [TBL] [Abstract][Full Text] [Related]